ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sanofi to license multiple myeloma target domain from Eureka and MSK
July 08, 2021Sanofi has signed a licence agreement with Eureka Therapeutics and Memorial Sloan Kettering Cancer Center (MSK) for non-CAR use of a new human binding domain for the potential treatment of multiple myeloma. -
Eureka initiates trial to evaluate ET140203 ARTEMIS T Cell Therapy in HCC
October 10, 2020Eureka Therapeutics, Inc. announced the Company has initiated a Phase I/II clinical trial of its ET140203 ARTEMIS T cell therapy in adult patients with hepatocellular carcinoma (HCC), the predominant type of liver cancer.
Pharma Sources Insight January 2025
